Ligand validation:7XMA

CDL: CARDIOLIPIN

CDL is a Ligand Of Interest in 7XMA designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
7XMA_CDL_P_304	4%	33%	0.326	0.708	1.31	1.33	12	13	16	0	100%	1
7XMA_CDL_C_302	3%	31%	0.343	0.679	1.33	1.42	12	13	20	0	100%	1
7XMA_CDL_T_103	2%	35%	0.369	0.651	1.31	1.25	12	7	30	0	100%	1
7XMA_CDL_G_103	1%	32%	0.4	0.632	1.32	1.36	12	8	21	0	100%	1
6JY3_CDL_B_301	33%	24%	0.163	0.908	1.53	1.57	5	14	0	0	64%	1
6JUW_CDL_C_307	31%	25%	0.195	0.862	1.4	1.66	14	17	19	0	100%	1
6JY4_CDL_B_301	29%	25%	0.183	0.904	1.42	1.6	4	13	2	0	64%	1
7D5X_CDL_C_308	27%	29%	0.184	0.86	1.27	1.57	10	12	13	0	85%	1
7CP5_CDL_P_304	24%	42%	0.181	0.878	1.22	1.05	7	4	4	0	61%	1
9GCX_CDL_C_504	62%	68%	0.143	0.934	0.43	0.79	-	2	16	0	100%	1
5Y5S_CDL_M_415	41%	34%	0.128	0.953	1.32	1.27	3	3	1	0	39%	1
2GNU_CDL_M_1309	38%	22%	0.122	0.984	1.77	1.5	3	3	0	0	10%	1
3ZDQ_CDL_A_1721	37%	64%	0.215	0.943	0.72	0.65	4	4	28	1	84%	0.5
7A0W_CDL_A_501	32%	37%	0.15	0.908	1.28	1.2	4	6	2	0	52%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.